{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T02:02:16Z","timestamp":1771639336856,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"UCB Trading Co Ltd."},{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.parkreldis.2016.04.022","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T07:04:44Z","timestamp":1461999884000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study"],"prefix":"10.1016","volume":"28","author":[{"given":"Zhen-Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Fang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengdi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinlu","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Surmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Asgharnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2016.04.022_bib1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1176\/jnp.2009.21.4.413","article-title":"Anxiety, depression, and quality of life in Parkinson's disease","volume":"21","author":"Quelhas","year":"2009","journal-title":"J.\u00a0Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2165\/00002512-200623090-00001","article-title":"A\u00a0review of the health-related quality of life and economic impact of Parkinson's disease","volume":"23","author":"Dowding","year":"2006","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib4","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2147\/NDT.S85380","article-title":"Systematic review of the prevalence and incidence of Parkinson's disease in the People's Republic of China","volume":"11","author":"Zou","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cns.12239","article-title":"Long-acting versus standard non-ergot dopamine agonists in Parkinson's disease: a meta-analysis of randomized controlled trials","volume":"20","author":"Zhou","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40265-015-0377-y","article-title":"An update on pharmacological, pharmacokinetic properties and drug-drug interactions of rotigotine transdermal system in Parkinson's disease and restless legs syndrome","volume":"75","author":"Elshoff","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000252355.79284.22","article-title":"Randomized, blind, controlled trial of transdermal rotigotine in early Parkinson disease","volume":"68","author":"Watts","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib8","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1002\/mds.21741","article-title":"Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole","volume":"22","author":"Giladi","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib10","series-title":"ECDEU Assessment Manual for Psychopharmacology","first-page":"217","article-title":"028.CGI. Clinical global Impressions","author":"National Institute of Mental Health","year":"1976"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib12","first-page":"5","article-title":"Compulsive buying: descriptive characteristics and psychiatric comorbidity","volume":"55","author":"Christenson","year":"1994","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","article-title":"The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults","volume":"168","author":"Posner","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A\u00a0new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.parkreldis.2008.07.004","article-title":"Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis","volume":"15","author":"Baker","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cns.12239","article-title":"Long-acting versus standard non-ergot dopamine agonists in Parkinson's disease: a meta-analysis of randomized controlled trials","volume":"20","author":"Zhou","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-0500-7-65","article-title":"Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China","volume":"7","author":"Zhang","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.parkreldis.2016.04.022_bib18","first-page":"497","article-title":"Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease","volume":"69","author":"Chase","year":"1996","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.parkreldis.2016.04.022_bib19","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ncl.2013.04.012","article-title":"The development of the rotigotine transdermal patch: a historical perspective","volume":"31","author":"Waters","year":"2013","journal-title":"Neurol. Clin."}],"updated-by":[{"DOI":"10.1016\/j.parkreldis.2017.02.030","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000}}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016301262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802016301262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:19Z","timestamp":1761178459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802016301262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":19,"alternative-id":["S1353802016301262"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.022","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}